APMC
APMCCIK 0002101393
Small by assets
Assets $146M
as of Oct 11, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (WS 10-Q) is open in full — no account needed.
10-Q
Filed Aug 13, 2026
· Period ending Jun 30, 2026
Summary not yet generated.
8-K
Filed Aug 5, 2026
· Period ending Jul 31, 2026
Summary not yet generated.
Partner
Trade APMC commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed Jun 25, 2026
· Period ending Jun 25, 2026
Summary not yet generated.
8-K
Filed Jun 18, 2026
· Period ending Jun 4, 2026
Summary not yet generated.
8-K
Filed Jun 12, 2026
· Period ending Jun 8, 2026
Summary not yet generated.
S-1/A
Filed May 22, 2026
Critical
APMC, a blank check company, files S-1/A for 12.5M units at $10.00 each, targeting $126.2M net proceeds
7 material changes detected. Sign up free to read the summary.
Latest financial statements
From 10-Q filed Aug 13, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Statement of Operations (Unaudited)
| Description | Three months ended June 30, 2026 | Six months ended June 30, 2026 |
|---|---|---|
| Formation and operating costs | 148,627 | 200,989 |
| Loss from operations | (148,627) | (200,989) |
| Other income (loss): | ||
| Earnings on marketable securities held in Trust Account | 357,187 | 357,187 |
| Change in over-allotment liability | (16,474) | (16,474) |
| Interest income | 49 | 49 |
| Net income | 192,135 | 139,773 |
| Basic weighted average shares outstanding, Ordinary Shares subject to redemption | 3,975,275 | 1,998,619 |
| Basic net income per Ordinary Share subject to redemption | 0.02 | 0.02 |
| Basic weighted average shares outstanding, Ordinary Shares not subject to redemption | 4,706,682 | 4,411,022 |
| Basic net income per Ordinary Share not subject to redemption | 0.02 | 0.02 |
| Diluted weighted average shares outstanding Ordinary Shares subject to redemption | 3,975,275 | 1,998,619 |
| Diluted net income per Ordinary Share subject to redemption | 0.02 | 0.02 |
| Diluted weighted average shares outstanding Ordinary Shares not subject to redemption | 5,211,994 | 4,965,642 |
| Diluted net income per Ordinary Share not subject to redemption | 0.02 | 0.02 |
Condensed Balance Sheets
| Description | June 30, 2026 (Unaudited) | December 31, 2025 |
|---|---|---|
| Current assets: | ||
| Cash | 796,296 | - |
| Due from Sponsor | 52,297 | - |
| Prepaid insurance | 67,962 | - |
| Prepaid expenses | 9,809 | 21,232 |
| Total current assets | 926,364 | 21,232 |
| Marketable securities held in Trust Account | 145,165,937 | - |
| Prepaid insurance noncurrent | 56,604 | - |
| Deferred offering costs | - | 85,000 |
| TOTAL ASSETS | 146,148,905 | 106,232 |
| LIABILITIES, REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS’ EQUITY (DEFICIT): | ||
| Current liabilities: | ||
| Accrued expenses | 27,833 | - |
| Accounts payable | 59,753 | - |
| Due to Sponsor | - | 60,947 |
| Due to a related party | - | 25,000 |
| Accrued offering costs | 110,000 | 35,000 |
| Total Current Liabilities | 197,586 | 120,947 |
| Commitments and Contingencies (Note 7) | ||
| Ordinary Shares subject to possible redemption, 14,337,500 shares at redemption value of $10.12 per share as of June 30, 2026 and none outstanding as of December 31, 2025 | 145,165,937 | - |
| Shareholders’ Equity (Deficit): | ||
| Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding as of June 30, 2026 | - | - |
| Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 5,621,075 issued and outstanding as of June 30, 2026, excluding 14,337,500 shares subject to possible redemption and 1 share issued and outstanding as of December 31, 2025 | 562 | - |
| Additional paid-in capital | 659,762 | - |
| Retained earnings (Accumulated deficit) | 125,058 | (14,715) |
| Total Shareholders’ Equity (Deficit) | 785,382 | (14,715) |
| TOTAL LIABILITIES, REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS’ EQUITY (DEFICIT) | 146,148,905 | 106,232 |
Condensed Statement of Cash Flows (Unaudited)
| Description | Six months ended June 30, 2026 |
|---|---|
| Net Income | 139,773 |
| Adjustments to reconcile net income to net cash used in operating activities: | |
| Earnings on marketable securities held in Trust Account | (357,187) |
| Change in over-allotment liability | 16,474 |
| Changes in operating assets and liabilities: | |
| Due from Sponsor | (25,862) |
| Prepaid insurance | (67,962) |
| Accrued expenses | 27,833 |
| Prepaid expenses | 11,423 |
| Prepaid insurance noncurrent | (56,604) |
| Accounts payable | 59,753 |
| Due to Sponsor | (60,947) |
| Due to a related party | (25,000) |
| Net cash used in operating activities | (338,306) |
| Cash flows from investing activities: | |
| Cash deposited into Trust Account | (144,808,750) |
| Net cash used in investing activities | (144,808,750) |
| Cash flows from financing activities: | |
| Proceeds from sale of Units, net of underwriting fees and reimbursement paid | 140,632,500 |
| Proceeds from Private Placement Units | 5,676,250 |
| Payment of offering costs | (365,398) |
| Net cash provided by financing activities | 145,943,352 |
| Net increase in cash | 796,296 |
| Cash beginning of year | - |
| Cash end of year | 796,296 |
| Supplemental disclosure of non-cash investing and financing activities: | |
| Accretion of Ordinary Shares subject to redemption to redemption value | 6,566,156 |
| Allocation of proceeds to Public Rights | 1,577,125 |
| Allocation of offering costs | 1,212,305 |
| Allocation for the Transfer of Founder Shares to third-party investors | 1,158,975 |
| Payment of Founder Shares included in Due from Sponsor | 26,435 |
| Forfeiture of Founder Shares | 2 |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗